Enhancing Natural Killer Cell-Mediated Lysis of Lymphoma Cells by Combining Therapeutic Antibodies With CD20-Specific Immunoligands Engaging NKG2D or NKp30
Blood - United States
doi 10.1182/blood.v124.21.1779.1779
Full Text
Open PDFAbstract
Available in full text
Date
December 6, 2014
Authors
Publisher
American Society of Hematology